Electromed, Inc. (ELMD)
NYSEAMERICAN: ELMD · Real-Time Price · USD
24.77
+4.11 (19.89%)
At close: Aug 27, 2025, 4:00 PM
24.77
0.00 (0.00%)
After-hours: Aug 27, 2025, 8:00 PM EDT
Electromed Revenue
In the fiscal year ending June 30, 2025, Electromed had annual revenue of $64.00M with 16.97% growth. Electromed had revenue of $17.39M in the quarter ending June 30, 2025, with 17.27% growth.
Revenue (ttm)
$64.00M
Revenue Growth
+16.97%
P/S Ratio
3.27
Revenue / Employee
$355,556
Employees
180
Market Cap
206.81M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 64.00M | 9.28M | 16.97% |
Jun 30, 2024 | 54.72M | 6.65M | 13.83% |
Jun 30, 2023 | 48.07M | 6.41M | 15.38% |
Jun 30, 2022 | 41.66M | 5.90M | 16.51% |
Jun 30, 2021 | 35.76M | 3.29M | 10.12% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ELMD News
- 23 hours ago - Electromed, Inc. (ELMD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Electromed, Inc. Announces Record Fiscal 2025 Fourth Quarter and Full Year Financial Results - Business Wire
- 15 days ago - Electromed, Inc. to Report Q4 Fiscal 2025 Financial Results on August 26, 2025 - Business Wire
- 4 weeks ago - Electromed, Inc. to Participate in the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 2 months ago - Electromed, Inc. to Present at the Investor Summit Virtual on June 10, 2025 - Accesswire
- 3 months ago - Electromed, Inc. to Join Russell 2000® and Russell 3000® Indexes - Business Wire
- 3 months ago - Electromed, Inc. (ELMD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Electromed, Inc. Announces Fiscal 2025 Third Quarter Results - Business Wire